The United States has recently — and belatedly — come to recognize opioid addiction as a public health crisis. What has …

(Amendment) Act of 2005, which introduced product patent protection for pharmaceuticals for the first time since 1972. Although …

We use a natural experiment in China’s health care reform, in which the government mandated zero markups for drugs sold …, and that the reform has little impact on the quality of health care proxied by the readmission rate …

public health.Unless WTO members reach a consensus, the multilateral trading system may be further complicated by a delay …

are needed. The way forward should involve a global approach that engages all relevant actors and looks beyond the health …

We use a natural experiment in China’s health care reform, in which the government mandated zero markups for drugs sold …, and that the reform has little impact on the quality of health care proxied by the readmission rate …

, and overestimates of the costs. We conclude that critics of DTC and calls for moratoria or bans on such advertising are …

Patents are often portrayed as the necessary reward to compensate pharmaceutical firms for the huge costs and risks …

driving the costs of pharmaceuticals, and develop a structured vector autoregressive (SVAR) model to measure the social rate …This study examines the relationship between pharmaceutical R&D and health care expenditures, distinguishing between … patents are not correlated with higher short-run prices in any measure of medical costs. They are associated with higher long …